This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Usv Private Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Sachin Shivaji Patil: Innovator in Pharmaceutical Chemistry
Introduction
Sachin Shivaji Patil is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceutical chemistry. His work focuses on the synthesis of important compounds that have therapeutic applications.
Latest Patents
Sachin holds a patent for the synthesis of Dabigatran etexilate, which is a crucial anticoagulant medication. The patent details a process for preparing Dabigatran etexilate or its pharmaceutically acceptable salts. It also introduces novel compounds, specifically Ethyl-3-{[(2-formyl-1-methyl-1H-benzimidazole-5-yl)carbonyl]-(2-pyridinyl) amino}propanoate and Ethyl-3-{[(2-dichloromethyl-1-methyl-1H-benzimidazole-5-yl)carbonyl]-(2-pyridinyl)amino}propanoate. These compounds are essential in the preparation of Dabigatran etexilate.
Career Highlights
Sachin is currently associated with USV Private Limited, where he continues to innovate in the pharmaceutical sector. His work has led to advancements in drug formulation and synthesis, contributing to better healthcare solutions.
Collaborations
He has collaborated with notable colleagues such as Nitin Dnyaneshwar Arote and Harish Kashinath Mondkar. These collaborations have enhanced the research and development efforts within his organization.
Conclusion
Sachin Shivaji Patil is a prominent figure in pharmaceutical innovation, with a focus on the synthesis of vital compounds. His contributions are paving the way for advancements in medication and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile